ОФФ-ЛЕЙБЛ НАЗНАЧЕНИЯ ЛЕКАРСТВЕННЫХ ПРЕПАРАТОВ В ДЕТСКОЙ ОФТАЛЬМОЛОГИЧЕСКОЙ ПРАКТИКЕ

N.K.  Uskenbaev; U.M.  Tilekeeva

doi:10.54890/.v5i5.663

N.K. Uskenbaev U.M. Tilekeeva

DOI:

https://doi.org/10.54890/.v5i5.663

Abstract

Pharmacoepidemiological, retrospective study of the prescriptions of medicines to 205 sick children with ophthalmologists. The reference source is the Kazakhstan National Formulary of Medicines. 79% of children were with inflammatory diseases, 21% with eye injuries. Children aged: 0-1 year 76.5% of appointments off-label; 1-3 years - 5.3%; 3-6 years - 13%; 6 years and older - 15.4%. The off-label included unregulated ways of administration, contraindicated at a certain age and inappropriate doses of drugs. In 100% of cases, antibacterial agents were prescribed, 19 titles were used, 4 were not described in the formulary, 8 antibiotics were used inappropriately. 3 drugs are contraindicated in childhood, 5 do not correspond to the indication of
age and dosage regimen.

Keywords:

medications, off-label prescriptions, children, eye diseases, drugs formular, antibiotics

References

1. Sutcliffe A.G. Prescribing medicines for children. Br Med J 1999; 319: 70-71.

2. Зырянов С.К. Использование нерекомендованных лекарств в педиатрии. Педиатрия 2005; 5: 19-21.

3. Cuzzolin L., Zaccaron A., Fanos V. Unlicensed and off label uses o f drugs in paediatrics: a review o f the literature. Fund Clin Pharmacol 2003; 17: 125-131.

4. Lifshitz M., Gavrilov V., Gorodischer R. O ff label and unlicensed use o f antidotes in paediatric patients. Eur J Clin Pharmacol 2001; 56: 839-841.

5. Langerova P., Vrtal J., Urbanek K. Incidence o f unlicensed and off-label prescription in children. Ital J Pediatric.2014; 40: 12.

6. Maltz L.A., Klugman D., Spaeder M.C., Wessel D.L. Off-label drug use in a single-center pediatric cardiac intensive care unit. World J Pediatric Congenic Heart Surg. 2013 Jul; 4 (3): 262-266.

7. Lee J.L., Redzuan A.M., Shah N.M. Unlicensed and off-label use o f medicines in children admitted to the intensive care units o f a hospital in Malaysia. Int J Clin Pharm. 2013 Dec; 35 (6): 1025-9.

8. Impicciatore P., Choonara I., Clarkson A. et al. Incidence o f adverse drug reactions in paediatric in/outpatients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2002; 52: 77-83.

9. Carleton B.C. et al. Pediatric adverse drug reaction reporting: understanding and future directions. Can. J. Pharmacol 2007; 14 (1): e 45-7.

10. Menniti-Ippolito G., Raschetti R., Da Cas R. et al. Active monitoring o f adverse drug reactions in children. Italian Paediatric Pharmaco surveillance Multicenter Group. Lancet 2000; 355: 1613-1614.

11. Титова А.Р., Асецкая И.Л., Зырянов С.К., Поливанов В.А. Нерегламентированное (off-label) применение лекарственных препаратов в педиатрической практике: нерешенные проблемы. Педиатрическая фармакология. 2015; 12 (3): 304-308.

12. Грацианская А.Н., Бологов А.А., Костылева М.Н., Постников С.С. Применение лекарственных средств off-label в педиатрической практике. Опыт многопрофильного педиатрического стационара. Заместитель главного врача. 2012; 8: 46 52.

13. Казахстанский национальный лекарственный формуляр электронный доступ:

http://knf.kz/index.php/ru/formulary-ru/monographstreatments.